首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1439981

電子藥局 - 全球市場考量、競爭格局、市場預測 (2030)

ePharmacy - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球電子藥局市場規模預計到2023年將達到604億美元，到2030年將達到1,888.9億美元，2024-2030年預測期間複合年增長率為21.05%。對電子藥局的需求是由於精通技術的消費者數量的增加、最終用戶對基於網路和線上服務的訪問迅速增加、醫院和其他醫療保健服務中電子處方的日益採用以及電子處方的採用而推動的。遠距醫療服務的成長。這得益於遠距醫療服務的增加此外，慢性病患者數量不斷增加，易患各種慢性病的老齡化人口負擔不斷加重，智慧型手機的普及，數位化的進步，採用電子藥局帶來的好處超過傳統藥局和線上處方藥的增加，受到優惠、折扣等等以及易於獲取的推動，這有助於電子藥房市場在2024-2030年預測期內的整體成長。

電子藥局市場動態

由於多種因素，電子藥房市場的產品需求不斷增長，其中主要因素之一是醫療保健領域越來越多地採用數位技術和電子商務。例如，醫療產業的成長和高昂的營運成本需要使用電子藥局解決方案來降低營運成本。隨著慢性病變得越來越普遍，對眾多醫療產品（尤其是藥品）的需求不斷增加。

此外，全球網路和智慧型手機的日益普及將增加對電子藥局服務的需求。例如，根據國際電信聯盟 (ITU) (2022) 的報告，預計 2022 年將有 53 億人（佔世界人口的 66%）使用網路。

電子處方的一大優點在於，您可以輕鬆地在電子藥局網站上傳電子處方，並無障礙地在線訂購藥品。因此，醫院和其他醫療服務中越來越多地採用電子處方系統也推動了線上藥局產業的發展。收集、儲存和檢索資訊的成本很高，因此實施電子處方對於解決關鍵成本問題至關重要。

受疫情影響，遠距問診服務驟增，電子藥局需求不斷增加。儘管醫療商店被列為基本服務，但網路藥局仍成為疫情封鎖的最大受益者之一。

對電子藥局不斷增長的需求也導致了新創公司、融資、收購和其他策略活動的增加。例如，2022 年 1 月，創投家馬克庫班 (Mark Cuban) 推出了一家數位藥房，以低價銷售 100 多種仿製藥，創造了徹底的透明度。

此外，2020 年 8 月，電子商務公司Amazon India在班加羅爾開設了Amazon Pharmacy。除了非處方藥和處方藥外，企業還提供基本醫療服務和傳統印度草藥。因此，上述因素正在推動2024-2030年預測期內電子藥局市場的成長。

然而，非法網路藥局的增加和假藥風險可能會限制電子藥局市場的成長。

電子藥局市場細分分析

在電子藥局市場的藥品類型部分，非處方藥類別預計將在 2023 年獲得可觀的收入佔有率。這是由於市場上容易獲得而最終用戶的需求不斷增加。

非處方藥通常治療易於自我診斷的疾病，例如頭痛、感冒和過敏，可在雜貨店、藥局、便利商店和超市購買。因此，易於獲得、消費者意識的提高以及各種常見健康問題的低成本治療是推動該細分市場需求的關鍵因素。

本報告提供了全球電子藥局市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

The global ePharmacy market was valued at USD 60.40 billion in 2023, growing at a CAGR of 21.05% during the forecast period from 2024 to 2030 to reach USD 188.89 billion by 2030. The demand for ePharmacy is being boosted by the increasing number of tech-savvy consumers, surging access to web-based and online services among the end-users, rising implementation of E-prescriptions in hospitals and other healthcare services, and the increasing adoption of telemedicine services across, among others. In addition, the rising patient population suffering from chronic diseases, the rising burden of the geriatric population prone to different chronic diseases, increasing penetration of smartphones, the increasing digitization and benefits associated with the adoption of ePharmacy over traditional pharmacies, lucrative offers and discounts along with easy availability of online prescription drugs, among others are thereby contributing to the overall growth of the ePharmacy market during the forecast period from 2024-2030.

Epharmacy Market Dynamics:

The ePharmacy market is witnessing a growth in product demand owing to various factors, one of the key factors being the increasing adoption of digital technologies and e-commerce in the healthcare sector. For instance, the growing healthcare industry and high operating costs have made it necessary to use ePharmacy solutions to reduce operational costs. Demand for numerous healthcare products, especially medications, is rising as chronic illnesses become more common.

Further, the rising adoption of the internet and smartphones across the globe will increase the demand for ePharmacy services. For instance, International Telecommunication Union (ITU) 2022, report stated that an estimated 5.3 billion people, or 66 percent of the world's population, used the internet in 2022.

The significant advantage of e-prescription is that one can easily upload their e-prescription on the e-pharmacy website and order medicine online without any hurdle. Thus, the rising implementation of e-prescribing systems in hospitals and other healthcare services is also driving the online pharmacy industry. The introduction of e-prescription is essential since it addresses a significant cost issue as it takes money to handle collecting, storing, and searching for information.

The pandemic has increased the demand for ePharmacy as there was a sudden thrust observed in teleconsulting services. Although medical stores were classified as vital services, still online pharmacies emerged as one of the largest beneficiaries of the pandemic-induced lockdown, as individuals preferred to buy medicines online to avoid the risk of disease spreading.

The rising demand for ePharmacy also leads to increased strategic activities including launches, funding, acquisitions, and others. For instance, in January 2022, Mark Cuban, the venture capitalist, launched a digital pharmacy that sells more than 100 generic pharmaceuticals at a low cost, to be radically transparent.

Also, in August 2020, E-commerce firm Amazon India launched Amazon Pharmacy, in Bengaluru. It offers both OTC and prescription drugs as well as basic health services and traditional Indian herbal medicines. Therefore, the above-mentioned factors are contributing to the growth of the ePharmacy market during the forecast period from 2024-2030.

However, the increasing number of illegal online pharmacies, the risk of counterfeit drugs, and others may restrict the ePharmacy market growth.

Epharmacy Market Segment Analysis:

ePharmacy Market by Drug Type (prescription drugs and over-the-counter (OTC) drugs), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World)

In the drug type segment of the ePharmacy market, the over-the-counter drugs category is expected to amass a significant revenue share in the year 2023. This can be attributed to its increased demand among the end-users owing to their easy availability in the market.

OTC drugs typically treat conditions that are easy to self-diagnose, such as headaches, colds, and allergies, and can be purchased at grocery stores, drug stores, convenience stores, and supermarkets. Thus, the easy availability, rising consumer awareness, and the ability to treat various common health issues at lower cost are some crucial factors hastening the segmental demand.

Further, the patient doesn't have to wait around while their prescription is processed, which also saves time. In comparison to patients who must go through an additional two steps to obtain the proper drug, OTC medications save the patient time overall and expedite the process of providing relief, thereby making OTC drugs a preferable option for consumers. Moreover, these drugs can be easily purchased through e-commerce platforms without the hassle of uploading a prescription and further placing the order of drugs.

Additionally, the economic benefits of OTC drug usage are attributable to savings on drug costs and costs incurred on a clinical visit. Also, Rx to OTC switch by pharmaceutical manufacturers, a growing tendency of people toward self-medication, and the inclination of customers towards online pharmacies are strongly driving the segmental growth.

Further, increasing initiatives by the government to increase the demand for OTC drugs will also propel the market of the segment. For instance, in January 2022, the Drugs Technical Advisory Board (DTAB) approved the new OTC policy under which Indian pharmacists will allow the sale of certain medicines without a prescription, as per new over the counter (OTC) policy for drugs. The medicines like antifungal infections, analgesics (pain killers), cough syrups, decongestants, laxatives, antiseptics, medicines for gum infections, and others are approved in a list of OTC drugs by DTAB.

Thus, the above-mentioned factors are likely to propel the demand for over-the-counter (OTC) drugs, thereby contributing to the growth of the ePharmacy market during the forecast period from 2024-2030.

North America is expected to dominate the overall Epharmacy Market:

Among all the regions, North America is estimated to account for the largest share of the ePharmacy market in the year 2023. This domination is due to the rising preference for OTC drugs, increasing teleconsulting services in the region, increasing internet penetration, and rise in the adoption of digital technologies in the healthcare industry, among others will propel the market of ePharmacy in North America.

The consumer-friendly online experiences and other cutting-edge services made possible by the digital age are further driving the total market expansion in North America.

Additionally, it is anticipated that the e-pharmacy market in North America, particularly the United States, will be driven by the convenience of ordering medications from the comfort of home. The market's expansion in North America is also anticipated to be fueled by the high concentration of market participants and the adoption of cutting-edge technologies by key companies to enhance the experience of customers making online drug purchases.

Further owing to the rising demand for e-pharmacy led to a rise in the number of new players in the market. For instance, in February 2022, Medicure Inc. launched its national direct-to-consumer e-commerce pharmacy platform through its subsidiary, Marley Drug Pharmacy, in the United States. With this, Americans can buy FDA-approved pharmaceuticals at bargain prices on Marley Drug's new e-commerce website, which offers home delivery to all 50 states.

Also, in January 2022, Mark Cuban started an online pharmacy offering affordable generic medications under the name Mark Cuban Cost Plus Drug Company, a brand-new online pharmacy, in the United States.

Thus, all the above-mentioned factors will lead to an increase in the North America ePharmacy market growth during the forecasting period of 2022-2027.

Epharmacy Market Key Players:

Some of the key market players operating in the ePharmacy market include OptumRx, Inc., Rowlands Pharmacy, Walmart Stores, Inc, Walgreen Co., Amazon.com, CVS Health, Cigna, Giant Eagle, Inc., The Kroger Co., PharmEasy, Apollo Pharmacy, DocMorris AG, Netmeds.com, Well, Chemistdirect.co.uk, Healthxchange Pharmacy, LloydsPharmacy, 1Mg, Alto Pharmacy, MedsEngage, and others.

Recent Developmental Activities in the Epharmacy Market:

In September 2022, Amazon stated that it was planning to sell prescription medications online in Japan.

In January 2022, Hyphens Pharma International Limited, Singapore's largest specialty pharmaceutical as well as a consumer healthcare company, launched WellAway ePharmacy in the city-state. WellAway offers customers the ease of access to pharmaceutical services while also assisting doctors with teleconsultation

In August 2020, Reliance Retail announced the acquisition of a 60.0% equity stake in Netmeds for USD 83.0 million. The acquisition is aimed at enhancing the company's ability to offer affordable & high-quality healthcare products & services to its customers.

Key Takeaways from the Epharmacy Market Report Study

Market size analysis for current ePharmacy market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global ePharmacy market.

Various opportunities available for the other competitor in the ePharmacy market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current ePharmacy market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ePharmacy market growth in the coming future?

Target Audience who can be benefited from this Epharmacy Market Report Study

ePharmacy products providers

Research organizations and consulting companies

ePharmacy-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in ePharmacy

Various End-users who want to know more about the ePharmacy market and the latest technological developments in the ePharmacy market.

Frequently Asked Questions for the Epharmacy Market:

1. What is ePharmacy?

E-Pharmacy is a pharmacy that sells medicines on the Internet and delivers them to customers. It is an online pharmacy that operates over the Internet and provides medicines to consumers through mail or shipping companies

2. What is the market for global ePharmacy?

The global ePharmacy market was valued at USD 60.40 billion in 2023, growing at a CAGR of 21.05% during the forecast period from 2024 to 2030 to reach USD 188.89 billion by 2030.

3. What are the drivers for the global ePharmacy market?

The demand for ePharmacy is primarily being heightened by the surging internet across the globe, improving digitalization of healthcare services, increasing number of tech-savvy consumers, rising consumer preference for online purchases, increasing adoption of digital technologies and e-commerce in the healthcare sector among others, thereby contribute to the overall growth of the ePharmacy market during the forecast period from 2024-2030.

4. Who are the key players operating in the global ePharmacy market?

5. Which region has the highest share in the ePharmacy market?

North America is expected to dominate the overall ePharmacy market during the forecast period from 2024-2030. Factors such as the rising adoption of e-commerce, growing geriatric population, increasing online sales, developed healthcare infrastructure, positive attitude towards the adoption of new technologies, and the presence of key players in the region, among others will positively impact the North American ePharmacy market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and high awareness about telemedicine and online pharmacy services also helped the market growth in this region.

1.ePharmacy Market Report Introduction

2. ePharmacy Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. ePharmacy Market Key Factors Analysis

4.1. ePharmacy Market Drivers
- 4.1.1. The increasing number of tech-savvy consumers
- 4.1.2. Surging access to web-based and online services among the end-users
- 4.1.3. Rising implementation of E-prescriptions in hospitals and other healthcare services
- 4.1.4. Increasing adoption of telemedicine services across
4.2. ePharmacy Market Restraints and Challenges
- 4.2.1. The increasing number of illegal online pharmacies
- 4.2.2. Risk of counterfeit drugs
4.3. ePharmacy Market Opportunities
- 4.3.1. Increasing penetration in rural areas in developing countries
- 4.3.2. Collaboration of the offline and online pharmacies

5. ePharmacy Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. ePharmacy Market Layout

6.1. By Drug Type
- 6.1.1. Prescription Drugs
- 6.1.2. Over-the-counter (OTC) Drugs
6.2. By Geography
- 6.2.1. North America ePharmacy Market Size in USD million (2021-2030)
  - 6.2.1.1. United States ePharmacy Market Size in USD million (2021-2030)
  - 6.2.1.2. Canada ePharmacy Market Size in USD million (2021-2030)
  - 6.2.1.3. Mexico ePharmacy Market Size in USD million (2021-2030)
- 6.2.2. Europe ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.1. France ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.2. Germany ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.3. United Kingdom ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.4. Italy ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.5. Spain ePharmacy Market Size in USD million (2021-2030)
  - 6.2.2.6. Rest of Europe ePharmacy Market Size in USD million (2021-2030)
- 6.2.3. Asia-Pacific ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.1. China ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.2. Japan ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.3. India ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.4. Australia ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.5. South Korea ePharmacy Market Size in USD million (2021-2030)
  - 6.2.3.6. Rest of the Asia-Pacific ePharmacy Market Size in USD million (2021-2030)
- 6.2.4. Rest of the World (RoW) ePharmacy Market Size in USD million (2021-2030)
  - 6.2.4.1. Middle East ePharmacy Market Size in USD million (2021-2030)
  - 6.2.4.2. Africa ePharmacy Market Size in USD million (2021-2030)
  - 6.2.4.3. South America ePharmacy Market Size in USD million (2021-2030)

7. ePharmacy Market Company and Product Profiles

7.1. OptumRx, Inc.
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Rowlands Pharmacy
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. Walmart Stores, Inc
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Walgreen Co.
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. Amazon.com
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. CVS Health
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. Cigna
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. Giant Eagle, Inc.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. The Kroger Co.
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. PharmEasy
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. Apollo Pharmacy
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. DocMorris AG
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Netmeds.com
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. Well
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Chemistdirect.co.uk
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
7.16. Healthxchange Pharmacy
- 7.16.1. Company Overview
- 7.16.2. Company Snapshot
- 7.16.3. Financial Overview
- 7.16.4. Product Listing
- 7.16.5. Entropy
7.17. LloydsPharmacy
- 7.17.1. Company Overview
- 7.17.2. Company Snapshot
- 7.17.3. Financial Overview
- 7.17.4. Product Listing
- 7.17.5. Entropy
7.18. 1Mg
- 7.18.1. Company Overview
- 7.18.2. Company Snapshot
- 7.18.3. Financial Overview
- 7.18.4. Product Listing
- 7.18.5. Entropy
7.19. Alto Pharmacy
- 7.19.1. Company Overview
- 7.19.2. Company Snapshot
- 7.19.3. Financial Overview
- 7.19.4. Product Listing
- 7.19.5. Entropy
7.20. MedsEngage
- 7.20.1. Company Overview
- 7.20.2. Company Snapshot
- 7.20.3. Financial Overview
- 7.20.4. Product Listing
- 7.20.5. Entropy